These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 22261022)

  • 1. Chemical-genomic profiling: systematic analysis of the cellular targets of bioactive molecules.
    Andrusiak K; Piotrowski JS; Boone C
    Bioorg Med Chem; 2012 Mar; 20(6):1952-60. PubMed ID: 22261022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining functional genomics and chemical biology to identify targets of bioactive compounds.
    Ho CH; Piotrowski J; Dixon SJ; Baryshnikova A; Costanzo M; Boone C
    Curr Opin Chem Biol; 2011 Feb; 15(1):66-78. PubMed ID: 21093351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeast genomics and proteomics in drug discovery and target validation.
    Parsons AB; Geyer R; Hughes TR; Boone C
    Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical genomic profiling via barcode sequencing to predict compound mode of action.
    Piotrowski JS; Simpkins SW; Li SC; Deshpande R; McIlwain SJ; Ong IM; Myers CL; Boone C; Andersen RJ
    Methods Mol Biol; 2015; 1263():299-318. PubMed ID: 25618354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of yeast genomic assays for drug and target discovery.
    Smith AM; Ammar R; Nislow C; Giaever G
    Pharmacol Ther; 2010 Aug; 127(2):156-64. PubMed ID: 20546776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic and genetic approaches for the identification of antifungal drug targets.
    Agarwal AK; Xu T; Jacob MR; Feng Q; Li XC; Walker LA; Clark AM
    Infect Disord Drug Targets; 2008 Mar; 8(1):2-15. PubMed ID: 18473903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the mode of action of bioactive compounds.
    Azad MA; Wright GD
    Bioorg Med Chem; 2012 Mar; 20(6):1929-39. PubMed ID: 22300885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast chemical genomics and drug discovery: an update.
    Hoon S; St Onge RP; Giaever G; Nislow C
    Trends Pharmacol Sci; 2008 Oct; 29(10):499-504. PubMed ID: 18755517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical genetic and chemogenomic analysis in yeast.
    Coorey NV; Sampson LD; Barber JM; Bellows DS
    Methods Mol Biol; 2014; 1205():169-86. PubMed ID: 25213245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical-genetic approaches for exploring the mode of action of natural products.
    Lopez A; Parsons AB; Nislow C; Giaever G; Boone C
    Prog Drug Res; 2008; 66():237, 239-71. PubMed ID: 18416308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target identification of small molecules based on chemical biology approaches.
    Futamura Y; Muroi M; Osada H
    Mol Biosyst; 2013 May; 9(5):897-914. PubMed ID: 23354001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Decade of genomics--methods for genome investigation in yeast Saccharomyces cerevisiae].
    Skoneczna A
    Postepy Biochem; 2006; 52(4):435-47. PubMed ID: 17536513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in the study of fungal virulence factors and identification of new targets of anti-fungal drug using proteomic and transcriptomic analysis].
    Toyotome T; Watanabe A; Kamei K
    Nihon Rinsho; 2008 Dec; 66(12):2255-60. PubMed ID: 19069088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast and drug discovery.
    Hughes TR
    Funct Integr Genomics; 2002 Sep; 2(4-5):199-211. PubMed ID: 12192593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting drug-target interactions through integrative analysis of chemogenetic assays in yeast.
    Heiskanen MA; Aittokallio T
    Mol Biosyst; 2013 Apr; 9(4):768-79. PubMed ID: 23420501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From drug to protein: using yeast genetics for high-throughput target discovery.
    Armour CD; Lum PY
    Curr Opin Chem Biol; 2005 Feb; 9(1):20-4. PubMed ID: 15701448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution chemical dissection of a model eukaryote reveals targets, pathways and gene functions.
    Hoepfner D; Helliwell SB; Sadlish H; Schuierer S; Filipuzzi I; Brachat S; Bhullar B; Plikat U; Abraham Y; Altorfer M; Aust T; Baeriswyl L; Cerino R; Chang L; Estoppey D; Eichenberger J; Frederiksen M; Hartmann N; Hohendahl A; Knapp B; Krastel P; Melin N; Nigsch F; Oakeley EJ; Petitjean V; Petersen F; Riedl R; Schmitt EK; Staedtler F; Studer C; Tallarico JA; Wetzel S; Fishman MC; Porter JA; Movva NR
    Microbiol Res; 2014; 169(2-3):107-20. PubMed ID: 24360837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-2009).
    Espinel-Ingroff A
    Rev Iberoam Micol; 2009 Mar; 26(1):15-22. PubMed ID: 19463273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of gene networks for drug target discovery and validation.
    Imoto S; Tamada Y; Savoie CJ; Miyano S
    Methods Mol Biol; 2007; 360():33-56. PubMed ID: 17172724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.